全文获取类型
收费全文 | 579篇 |
免费 | 33篇 |
国内免费 | 368篇 |
出版年
2023年 | 7篇 |
2022年 | 21篇 |
2021年 | 6篇 |
2020年 | 8篇 |
2019年 | 24篇 |
2018年 | 17篇 |
2017年 | 63篇 |
2016年 | 55篇 |
2015年 | 46篇 |
2014年 | 35篇 |
2013年 | 9篇 |
2012年 | 51篇 |
2011年 | 40篇 |
2010年 | 32篇 |
2009年 | 33篇 |
2008年 | 30篇 |
2007年 | 33篇 |
2006年 | 38篇 |
2005年 | 20篇 |
2004年 | 16篇 |
2003年 | 19篇 |
2002年 | 13篇 |
2001年 | 23篇 |
2000年 | 37篇 |
1999年 | 40篇 |
1998年 | 22篇 |
1997年 | 27篇 |
1996年 | 25篇 |
1995年 | 32篇 |
1994年 | 35篇 |
1993年 | 13篇 |
1992年 | 7篇 |
1991年 | 5篇 |
1990年 | 6篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 47篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1978年 | 3篇 |
1970年 | 2篇 |
1964年 | 2篇 |
1963年 | 2篇 |
1958年 | 1篇 |
1957年 | 1篇 |
1956年 | 1篇 |
排序方式: 共有980条查询结果,搜索用时 312 毫秒
101.
G De Serres MC Gariépy B Coleman I Rouleau S McNeil M Benoît A McGeer A Ambrose J Needham C Bergeron C Grenier K Sleigh A Kallos M Ouakki N Ouhoummane G Stiver L Valiquette A McCarthy J Bettinger;PHAC-CIHR influenza Research Network 《PloS one》2012,7(7):e38563
Background
This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monovalent pandemic vaccine through an active web-based electronic surveillance. We compared its safety profile to that of the seasonal trivalent inactivated influenza vaccine (TIV) for 2010–2011.Methodology/Principal Findings
Health care workers (HCW) vaccinated in 2009 with the pandemic vaccine (Arepanrix ® from GSK) or HCW vaccinated in 2010 with the 2010–2011 TIV were invited to participate in a web-based active surveillance of vaccine safety. They completed two surveys the day-8 survey covered the first 7 days post-vaccination and the day-29 survey covered events occurring 8 to 28 days after vaccination. Those who reported a problem were called by a nurse to obtain details. The main outcome was the occurrence of a new health problem or the worsening of an existing health condition that resulted in a medical consultation or work absenteeism. For the pandemic vaccine, a six-month follow-up for the occurrence of serious adverse events (SAE) was conducted. Among the 6242 HCW who received the pandemic vaccine, 440 (7%) reported 468 events compared to 328 of the 7645 HCW (4.3%) who reported 339 events after the seasonal vaccine. The 2009 pandemic vaccine was associated with significantly more local reactions than the 2010–2011 seasonal vaccine (1% vs. 0.03%, p<0.001). Paresthesia was reported by 7 HCW (0.1%) after the pandemic vaccine but by none after the seasonal vaccine. For the pandemic vaccine, no clustering of SAE was found in the 6 month follow-up.Conclusion
The 2009 pandemic vaccine seems to have a good safety profile, similar to the 2010–2011 TIV, with the exception of local reactions. This surveillance was adequately powered to identify AE associated with an excess risk ≥1 per 1000 vaccinations but is insufficient to detect rare AE.Trial Registration
ClinicalTrials.gov , NCT01289418 NCT01318876相似文献102.
103.
I Feinkohl N Sattar P Welsh RM Reynolds IJ Deary MW Strachan JF Price;on behalf of the Edinburgh Type Diabetes Study 《PloS one》2012,7(9):e44569
Background
Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS).Methodology and Principal Findings
Cross-sectional analysis of 1066 men and women aged 60–75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, ‘g’. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower ‘g’ and higher depression scores (ß −0.09, 95% CI −0.13 to −0.03, p = 0.004 and ß 0.08, 95% CI 0.04 to 0.12, p<0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of ‘g’) and ‘possible’ depression (HADS depression ≥8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (β −0.02, 95% CI −0.07 to 0.03, p>0.05 for ‘g’; β 0.03, 95% CI −0.02 to 0.07, p>0.05 for depression scores).Conclusion
Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions. 相似文献104.
通过缬氨酸和精氨酸的交替连接形成β-发卡结构的两条侧链,D-脯氨酸和甘氨酸形成β-转角单元以及侧链末端的两个半胱氨酸连接形成一个二硫键,来设计得到全新的由16残基构成的β-发卡抗菌肽VR。对设计得到的抗菌肽VR的生物学活性进行了检测,主要测定了新型β-发卡抗菌肽VR的最小杀菌浓度、对红细胞的溶血活性、杀菌动力学和盐敏感性。结果发现,VR和蜂毒素具有相似的杀菌活性,而溶血活性远低于蜂毒素,这表明VR比蜂毒素具有更高的细胞选择性。在NaCl的浓度低于100 mmol/L时,VR的杀菌活性没有受到影响;在NaCl的浓度为100 mmol/L时,VR具有50%的杀菌活性。综上可见,VR具有较优异的生物学活性,拥有成为抗生素替代物的发展潜力。 相似文献
105.
旨在构建稳定表达HCV核心蛋白的稳定细胞系Huh7-Core并进行初步的生物学功能研究.利用PCR技术扩增HCV核心蛋白基因,通过酶切连接反应将目的基因克隆至载体pSEB-3Flag中,将重组质粒pSEB-3F-Core和辅助质粒pAmpho共转染Huh7细胞,经过Blasticidine抗性筛选,建立稳定表达HCV核心蛋白的肝癌细胞系Huh7-Core.采用RT-PCR、Western blot鉴定Huh7-Core细胞株中核心蛋白的稳定表达并采用MTS、结晶紫试验观察Huh7-Core稳定细胞株的增殖情况.结果显示,成功构建了表达HCV核心蛋白的稳定细胞株Huh7-Core.结晶紫、MTS试验证实Huh7-Core细胞较Huh7-3Flag细胞增殖速度增快,表达HCV核心蛋白的Huh7-Core稳定细胞株构建成功,Core稳定表达后可促进Huh7细胞生长速度. 相似文献
106.
T Duong G Jourdain N Ngo-Giang-Huong S Le Cœur P Kantipong S Buranabanjasatean P Leenasirimakul S Ariyadej S Tansuphasawasdikul S Thongpaen M Lallemant;for the Program for HIV Prevention Treatment 《PloS one》2012,7(8):e43375
BACKGROUND: Data on determinants of long-term disease progression in HIV-infected patients on antiretroviral therapy (ART) are limited in low and middle-income settings. METHODS: Effects of current CD4 count, viral load and haemoglobin and diagnosis of AIDS-defining events (ADEs) after start of combination ART (cART) on death and new ADEs were assessed using Poisson regression, in patient aged ≥18 years within a multi-centre cohort in Thailand. RESULTS: Among 1,572 patients, median follow-up from cART initiation was 4.4 (IQR 3.6-6.3) years. The analysis of death was based on 60 events during 6,573 person-years; 30/50 (60%) deaths with underlying cause ascertained were attributable to infections. Analysis of new ADE included 192 events during 5,865 person-years; TB and Pneumocystis jiroveci pneumonia were the most commonly presented first new ADE (35% and 20% of cases, respectively). In multivariable analyses, low current CD4 count after starting cART was the strongest predictor of death and of new ADE. Even at CD4 above 200 cells/mm(3), survival improved steadily with CD4, with mortality rare at ≥500 cells/mm(3) (rate 1.1 per 1,000 person-years). Haemoglobin had a strong independent effect, while viral load was weakly predictive with poorer prognosis only observed at ≥100,000 copies/ml. Mortality risk increased following diagnosis of ADEs during cART. The decline in mortality rate with duration on cART (from 21.3 per 1,000 person-years within first 6 months to 4.7 per 1,000 person-years at ≥36 months) was accounted for by current CD4 count. CONCLUSIONS: Patients with low CD4 count or haemoglobin require more intensive diagnostic and treatment of underlying causes. Maintaining CD4≥500 cells/mm(3) minimizes mortality. However, patient monitoring could potentially be relaxed at high CD4 count if resources are limited. Optimal ART monitoring strategies in low-income settings remain a research priority. Better understanding of the aetiology of anaemia in patients on ART could guide prevention and treatment. 相似文献
107.
基因型-表现型复杂生物系统由多基因群调控,细胞发生的信号传导路径、多基因相互作用与细胞系谱定位形成生物系统的结构-图式发生遗传学,但分子、细胞和器官的结构、图式形成机理还不很清楚。复杂生物系统的图式演化是细胞的物种进化、细胞形态发育的细胞发生非线性动力学过程,包括:1)物种基因组结构内等位基因替代构成物种内基因多样性调控;2)物种间进化的基因组结构层次级别的自组织化。系统理论应用于系统生态学(Van Dyne GM.1966)、系统生理学(Sagawa K.1973)、系统心理学(Titchener EB.1992)、系统生物医学(Kamada T.1992)、系统生物学(zieglgansherger W,Tolle TR.1993)、系统生物工程与系统遗传学(Zengg:BJ.1994)的建立,以及遗传学机理的生物系统分析。细胞的基因组结构自组织化形成生物的系统发生,基因组的结构变化形成物种的适应变异,生物体结构的基因组复制与表达的细胞自组织化构成生物个体发生。基于系统遗传学的工程应用,合成生物学探索生物系统泛进化,包括人工生物体的遗传工程、基因调控和仿生智能的纳米生物机器,构成生物系统的人工引导进化。 相似文献
108.
109.
丙酮酸磷酸双激酶(pyruvate phosphate dikinase, PPDK; EC 2.7.9.1)能够可逆催化磷酸烯醇式丙酮酸(phosphoenolpyruvate, PEP)、单磷酸腺苷(adenosine monophosphate, AMP)和焦磷酸盐(pyrophosphate, PPi)生成三磷酸腺苷(adenosine triphosphate, ATP)、无机磷酸盐(orthophosphate, Pi)和丙酮酸(pyruvate).以热玫瑰小双孢菌基因组DNA为模板,PCR扩增得到了编码PPDK的基因,将此基因片段插入表达载体pET24a (+),在大肠杆菌中表达C端融合His-Tag的重组PPDK.与我们先前表达的N端融合His-Tag的PPDK相比,酶的活性提高了20倍,提示该酶的N端对活性十分重要.重组PPDK单体分子量为98 kD.经过镍亲和层析和超滤后,重组PPDK基本达到电泳纯.重组PPDK与荧光素酶偶联能够形成1个ATP-AMP循环反应,在该循环反应中,荧光素酶催化ATP生成的AMP和PPi能够被PPDK重新转化成ATP,产生一个持续稳定的信号. 相似文献
110.
Common displays such as CRT or LCD screens have hmlted capabilities in displaying most color spectra correctly. The main disadvantage of these devices is that they work with three primaries and the colors displayed are the mixture of these three colours. Consequently these devices can be confusing in testing human color identification, because the spectral distribution of the colors displayed is the combined spectrum of the three primaries. We have developed a new instrument for spectrally correct color vision measurement. This instrument uses light emitting diodes (LEDs) and is capable of producing all spectra of perceivable colors, thus with appropriate test methods this instrument can be a reliable and useful tool in testing human color vision and in verifying color vision correction. 相似文献